**Author details**

Aishat A. Motolani1 , Mengyao Sun1 , Matthew Martin1 , Steven Sun1 and Tao Lu1,2,3\*

1 Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA

2 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA

3 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA

\*Address all correspondence to: lut@iu.edu

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**15**

2019;**9**:489

*Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer*

and pathology. Current Opinion in Cell

[11] Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m 6 A decoration: Writers, erasers, readers and functions in RNA metabolism. Cell

[12] Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell.

[13] Smith BC, Denu JM. Chemical mechanisms of histone lysine and arginine modifications. Biochim Biophy Acta (BBA)-Gene Regulatory Mechanisms. 2009;**1789**(1):45-57

[14] Tsukada YI, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, et al. Histone demethylation

by a family of JmjC domaincontaining proteins. Nature. 2006;**439**(7078):811-816

[15] Yun M, Wu J, Workman JL, Li B. Readers of histone modifications. Cell Research. 2011;**21**(4):564-578

[16] Portela A, Esteller M. Epigenetic modifications and human disease. Nature Biotechnology. 2010;**28**(10):1057

[17] Mulero-Navarro S, Esteller M. Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer. Epigenetics. 2008;**3**(4):210-215

[18] Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, et al. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Human Molecular Genetics.

[19] Sun XJ, Man N, Tan Y, Nimer SD,

2008;**17**(17):2633-2643

Wang L. The role of histone

Research. 2018;**28**(6):616-624

2018;**175**(7):1872-1886

Biology. 2014;**31**:1-7

*DOI: http://dx.doi.org/10.5772/intechopen.92830*

[1] Waddington CH. The epigenotype.

[3] Stefanelli G, Walters BJ, Ramzan F, Narkaj K, Tao C, Zovkic IB. Epigenetic mechanisms of learning and memory. In: Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research. Cambridge, Massachusetts: Academic Press; 2018. pp. 345-382

[4] Iwasaki W, Miya Y, Horikoshi N, Osakabe A, Taguchi H, Tachiwana H,

et al. Contribution of histone N-terminal tails to the structure and stability of nucleosomes. FEBS Open

[5] Gillette TG, Hill JA. Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circulation

Research. 2015;**116**(7):1245-1253

[7] Maunakea AK, Chepelev I, Cui K, Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Research.

[8] Carey N, Marques CJ, Reik W. DNA demethylases: a new epigenetic frontier in drug discovery. Drug Discovery Today. 2011;**16**(15-16):683-690

[9] Mahmood N, Rabbani SA. DNA methylation readers and cancer: Mechanistic and therapeutic applications. Frontiers in Oncology.

[10] Blanco S, Frye M. Role of RNA methyltransferases in tissue renewal

[6] Weber WW. Epigenetics. Comprehensive Medicinal Chemistry II. Vol. 1. Amsterdam, Netherlands: Elsevier; 2007. pp. 251-278

2013;**23**(11):1256-1269

Bio. 2013;**3**(1):363-369

[2] Kanwal R, Gupta S. Epigenetic modifications in cancer. Clinical Genetics. 2012;**81**(4):303-311

Endeavour. 1942;**1**:18-20

**References**

*Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer DOI: http://dx.doi.org/10.5772/intechopen.92830*
